[go: up one dir, main page]

AU2003219725A1 - Angiogenesis genes - Google Patents

Angiogenesis genes

Info

Publication number
AU2003219725A1
AU2003219725A1 AU2003219725A AU2003219725A AU2003219725A1 AU 2003219725 A1 AU2003219725 A1 AU 2003219725A1 AU 2003219725 A AU2003219725 A AU 2003219725A AU 2003219725 A AU2003219725 A AU 2003219725A AU 2003219725 A1 AU2003219725 A1 AU 2003219725A1
Authority
AU
Australia
Prior art keywords
angiogenesis genes
angiogenesis
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003219725A
Other versions
AU2003219725A8 (en
Inventor
Wufang Fan
Gilbert Jay
Karl F. Kovacs
Xuan Li
Zairen Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Origene Technologies Inc
Original Assignee
Origene Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/067,482 external-priority patent/US20030148407A1/en
Priority claimed from US10/164,595 external-priority patent/US6657054B1/en
Application filed by Origene Technologies Inc filed Critical Origene Technologies Inc
Publication of AU2003219725A8 publication Critical patent/AU2003219725A8/en
Publication of AU2003219725A1 publication Critical patent/AU2003219725A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/515Angiogenesic factors; Angiogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003219725A 2002-02-07 2003-02-07 Angiogenesis genes Abandoned AU2003219725A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US10/067,482 2002-02-07
US10/067,482 US20030148407A1 (en) 2002-02-07 2002-02-07 Human dehydrogenase gene and polypeptide
US10/164,595 2002-06-10
US10/164,595 US6657054B1 (en) 2002-06-10 2002-06-10 Regulated angiogenesis genes and polypeptides
US40364902P 2002-08-16 2002-08-16
US60/403,649 2002-08-16
US43774603P 2003-01-03 2003-01-03
US60/437,746 2003-01-03
PCT/US2003/003848 WO2003066831A2 (en) 2002-02-07 2003-02-07 Angiogenesis genes

Publications (2)

Publication Number Publication Date
AU2003219725A8 AU2003219725A8 (en) 2003-09-02
AU2003219725A1 true AU2003219725A1 (en) 2003-09-02

Family

ID=27739314

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003219725A Abandoned AU2003219725A1 (en) 2002-02-07 2003-02-07 Angiogenesis genes

Country Status (2)

Country Link
AU (1) AU2003219725A1 (en)
WO (1) WO2003066831A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7055683B2 (en) 2002-12-20 2006-06-06 E. I. Du Pont De Nemours And Company Multiple compartment pouch and beverage container with smooth curve frangible seal
WO2004113532A1 (en) * 2003-06-21 2004-12-29 Shigeki Higashiyama Protein for screening cytostatic agent, method of screening cytostatic agent and cytostatic agent
WO2009091023A1 (en) * 2008-01-17 2009-07-23 Toray Industries, Inc. Composition and method for diagnosis or detection of gastric cancer

Also Published As

Publication number Publication date
WO2003066831A3 (en) 2006-08-17
AU2003219725A8 (en) 2003-09-02
WO2003066831A2 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
AU2003218483A1 (en) Novel expressed genes
AU2002313559A1 (en) Genes
AU2003277149A1 (en) Synthetic genes
AU2002335152A1 (en) Robot-phone
AU2003224712A1 (en) Modulating angiogenesis
AU2001240103A1 (en) Reproduction-specific genes
AU2003212826A1 (en) Cancer genes
AU2003244347A1 (en) Angiogenesis inhibitors
AU2003219725A1 (en) Angiogenesis genes
AU2003222965A1 (en) Schizophrenia associated genes
AU2003294705A1 (en) NtSM GENE
AU2002318053A1 (en) Suplier
AU2001278042A1 (en) Daz genes
AU2003221324A1 (en) Angiogenesis inhibitors
AU2003267384A1 (en) Bhyd gene
AU2003241762A1 (en) Dna shuflling
EP1518929A4 (en) Novel genes
AU2002308879A1 (en) Stat6-activating genes
AU2002953459A0 (en) Stress genes
HK1069405A (en) Height-related gene
AU2002100075A4 (en) Bloodnut retreivable brackets
AU2002234752A1 (en) Hypoxia-regulated genes
AU2002100739A4 (en) Neuramax
AU2002100957A4 (en) Sluggit
AU2002100508A4 (en) Photocard

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase